Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 2003

View Archived Issues

Alcon claims three series of 5-HT2 agonists with utility in glaucoma therapy

Researchers report production of fully active antibodies in algae chloroplasts

Novel series of erythromycin analogues designed at Pfizer

Uniroyal researchers identify novel antiretroviral agents for HIV and HCMV infections

Water-soluble antifungal compounds covered by Sankyo patent

Novel antagonists of platelet ADP (P2YAC) receptors discovered at Schering AG

Celera patent covers the preparation and use of new cathepsin S inhibitors

Scientists at Boehringer Ingelheim present novel tachykinin antagonists and their uses

Hynic-Annexin V IND withdrawn, to be resubmitted at later date

AxCell Biosciences and Celgene team up for ubiquitin ligase research

ALT-711 reduces left ventricular mass in DIAMOND trial

Asmanex Twisthaler launched in U.K.

Lamictal approved for adjunctive use in pediatric partial seizures

Coley earns CpG-7279 milestone payment from Aventis

Phase I study initiated for P-63

RK-0202 enters phase II evaluation in oral mucositis

Inhale Therapeutic Systems becomes Nektar Therapeutics

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Inhibition of endogenous cannabinoid breakdown as a novel antianxiety strategy

Yamanouchi team discovers new antifungal antibiotic with novel mechanism

Novartis stops development of DRF-4158 but continues collaboration with Dr. Reddy's

Efficacy of TAK-427 in experimental model of atopic dermatitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...